Gala GLP-1 is a telehealth service that connects eligible patients with licensed healthcare providers for medical weight-loss treatment
As the program launches in 2026, it could become a helpful option for individuals managing obesity and related conditions
Evaluating Your Metabolic and Genetic Context Before Starting Before committing to a specific GLP-1 formulation, understanding your metabolic baselineincluding fasting glucose, insulin levels, and appetite-regulation biomarkerscan inform whether semaglutide, tirzepatide, or a dual-compound protocol may be most relevant to your clinical picture
This is why unit dosage in capsule formats is an important factor to consider , as the more quantity in each capsule, the easier it is to reach the recommended daily dose conveniently and efficiently
As of 2023, global sales are expected to reach a staggering $67.7 billion , with the United States alone accounting for $38.8 billion